XEOU:LSE:LSE-db x-trackers MSCI Europe UCITS (USD)

ETF | Others |

Last Closing

USD 17.269

Change

+0.10 (+0.56)%

Market Cap

USD 0.33B

Volume

5.44K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

N/A

USD 292,109.19B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 608.02B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 608.02B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

N/A

USD 329.34B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
0QZO:LSE 0QZO

N/A

USD 258.54B

ETFs Containing XEOU:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.51% 76% C+ 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.51% 76% C+ 73% C
Trailing 12 Months  
Capital Gain 20.56% 73% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.56% 72% C 72% C
Trailing 5 Years  
Capital Gain 58.88% 76% C+ 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 58.88% 74% C 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 10.82% 73% C 74% C
Dividend Return 10.82% 72% C 73% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.95% 53% F 70% C-
Risk Adjusted Return 83.57% 90% A- 94% A
Market Capitalization 0.33B 62% D 47% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike